The final-final logrank HR is now known to be close to 1.33 which improved from the 1.29 seen at the final look. If the trial continued longer, it is feasible that the HR will[sic] come close to 1.45…
This is irrelevant to the thread insofar as we were discussing the final analysis of the IMPACT study at 304 deaths, as specified in the SPA. The observed HR at 304 deaths was 1.29, not your bloated forecast of 1.45.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”